CONSOLIDATED STATEMENT OF STOCKHOLDERS' DEFICIENCY (USD $)
|
Common Stock Shares
|
Common Stock Amount
USD ($)
|
Additional Paid in Capital
USD ($)
|
Accumulated Deficit
USD ($)
|
Total
USD ($)
|
---|---|---|---|---|---|
Balance at Dec. 31, 2010 | 92,705,351 | 92,705 | 25,485,816 | (26,530,199) | (951,680) |
Issuance of warrants to board of directors | $ 0 | $ 87,278 | $ 0 | $ 87,278 | |
Issuance of stock to consultants | 137,594 | 138 | 34,862 | 0 | 35,000 |
Issuance of warrants to consultants | 0 | 8,584 | 0 | 8,584 | |
Issuance of common stock pursuant to private placements | 3,193,334 | 3,193 | 404,307 | 0 | 407,500 |
Issuance of common stock for cashless warrants | 82,667 | 83 | (83) | 0 | 0 |
Common stock issued in repayment of loan | 1,317,398 | 1,317 | 163,358 | 0 | 164,675 |
Exercise of common stock warrants | 2,600,000 | 2,600 | 257,400 | 0 | 260,000 |
Warrants issued for financing costs | 0 | 500,626 | 0 | 500,626 | |
Discounts on convertible debentures | 0 | 130,422 | 0 | 130,422 | |
Deferred finance charges | 0 | 57,706 | 0 | 57,706 | |
Rounding | (325) | 0 | 0 | 0 | 0 |
Net loss | 0 | 0 | (2,731,610) | (2,731,610) | |
Balance at Dec. 31, 2011 | 100,036,019 | 100,036 | 27,130,276 | (29,261,809) | (2,031,497) |
Issuance of warrants to board of directors | 0 | 48,429 | 0 | 48,429 | |
Issuance of common stock and warrants pursuant to private placements | 4,920,000 | 4,920 | 610,080 | 0 | 615,000 |
Cashless exercise of common stock warrants | 11,797 | 12 | (12) | 0 | 0 |
Exercise of common stock warrants | 350,000 | 350 | 34,650 | 0 | 35,000 |
Discounts on convertible debentures | 0 | 332,000 | 0 | 332,000 | |
Deferred finance charges | 0 | 293,282 | 0 | 293,282 | |
Net loss | $ 0 | $ 0 | $ (3,248,405) | $ (3,248,405) | |
Balance at Dec. 31, 2012 | 105,317,816 | 105,318 | 28,448,705 | (32,510,214) | (3,956,191) |
X | ||||||||||
- Definition
Cashless exercise of common stock warrants No definition available.
|
X | ||||||||||
- Definition
Common stock issued in repayment of loan No definition available.
|
X | ||||||||||
- Definition
The charge during the period representing the systematic and rational allocation of deferred finance costs over the term of the debt. No definition available.
|
X | ||||||||||
- Definition
Discounts on convertible debentures instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder. No definition available.
|
X | ||||||||||
- Definition
The amount from holders exercising their stock warrants. No definition available.
|
X | ||||||||||
- Definition
Issuance of common stock and warrants pursuant to private placements No definition available.
|
X | ||||||||||
- Definition
The value of Issuance of common stock for cashless warrants. No definition available.
|
X | ||||||||||
- Definition
The fair value of restricted stock or Issuance of stock to consultants. No definition available.
|
X | ||||||||||
- Definition
The fair value of restricted stock or stock warrants to board of directors granted. No definition available.
|
X | ||||||||||
- Definition
The fair value of restricted stock or Issuance of warrants to consultants. No definition available.
|
X | ||||||||||
- Definition
Rounding during the period. No definition available.
|
X | ||||||||||
- Definition
Warrants issued for financing costs No definition available.
|
X | ||||||||||
- Definition
This element represents the income or loss from continuing operations attributable to the economic entity which may also be defined as revenue less expenses and taxes from ongoing operations before extraordinary items, and noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Number of shares issued and outstanding as of the balance sheet date. No definition available.
|
X | ||||||||||
- Definition
Number of new stock issued during the period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|